Literature DB >> 12414169

Brucella vaccines in wildlife.

D S Davis1, P H Elzer.   

Abstract

Brucellosis has been known to exist in populations of wildlife since the early part of the 20th century. At the beginning of this century in the US, Brucella abortus is a problem in elk and bison in the Greater Yellowstone Area, B. suis is prevalent in millions of feral swine in most of the southern states, and caribou/reindeer in Alaska are infected with B. suis biovar 4. Brucellosis has been virtually eliminated in domestic livestock in the US after decades of expensive governmental disease prevention, control and eradication programs. Now the most likely source of transmission of brucellosis to humans, and the risk of reintroduction of brucellosis into livestock is from infected populations of free-ranging wildlife. Brucellosis was eradicated from livestock through a combination of testing, vaccination, and removal of infected animals. The use of vaccines to control brucellosis in populations of wildlife and therefore reducing the risk of transmission to humans and livestock has been proposed in several instances. This manuscript reviews research on the use of Brucella vaccines in species of wildlife with emphasis on safety and efficacy. Department of Veterinary Pathobiology, Texas A&M University

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414169     DOI: 10.1016/s0378-1135(02)00233-x

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  16 in total

1.  Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice.

Authors:  M M Kahl-McDonagh; T A Ficht
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Brucella abortus phosphoglyceromutase and dihydrodipicolinate reductase induce Th1 and Th2-related immune responses.

Authors:  Zhiqiang Li; Hui Zhang; Jinliang Zhang; Li Xi; Guangli Yang; Shuli Wang; Qingfeng Zhou; Xiaogen Zhang; Junbo Zhang
Journal:  World J Microbiol Biotechnol       Date:  2018-01-04       Impact factor: 3.312

3.  Bacillus Calmette-Guérin vaccination reduces the severity and progression of tuberculosis in badgers.

Authors:  Mark A Chambers; Fiona Rogers; Richard J Delahay; Sandrine Lesellier; Roland Ashford; Deanna Dalley; Sonya Gowtage; Dipesh Davé; Si Palmer; Jacky Brewer; Timothy Crawshaw; Richard Clifton-Hadley; Steve Carter; Chris Cheeseman; Chris Hanks; Alistair Murray; Kate Palphramand; Stéphane Pietravalle; Graham C Smith; Alexandra Tomlinson; Neil J Walker; Gavin J Wilson; Leigh A L Corner; Stephen P Rushton; Mark D F Shirley; George Gettinby; Robbie A McDonald; R Glyn Hewinson
Journal:  Proc Biol Sci       Date:  2010-12-01       Impact factor: 5.349

4.  Soluble expression and purification of Brucella cell surface protein (BCSP31) of Brucella melitensis and preparation of anti-BCSP31 monoclonal antibodies.

Authors:  Lei Zhang; Xing An Wu; Fang Lin Zhang; Cui Hong An; Yang Xin Sun; Wen Tao Bai; Zhi Kai Xu
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

5.  Brucella melitensis 16MΔTcfSR as a potential live vaccine allows for the differentiation between natural and vaccinated infection.

Authors:  Zhiqiang Li; Junbo Zhang; K E Zhang; Qiang Fu; Zhen Wang; Tiansen Li; Hui Zhang; Fei Guo; Chuangfu Chen
Journal:  Exp Ther Med       Date:  2015-07-06       Impact factor: 2.447

Review 6.  Brucellosis: the case for live, attenuated vaccines.

Authors:  Thomas A Ficht; Melissa M Kahl-McDonagh; Angela M Arenas-Gamboa; Allison C Rice-Ficht
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

7.  The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle.

Authors:  A M Arenas-Gamboa; T A Ficht; M M Kahl-McDonagh; G Gomez; A C Rice-Ficht
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

8.  Enhanced immune response of red deer (Cervus elaphus) to live rb51 vaccine strain using composite microspheres.

Authors:  Angela M Arenas-Gamboa; Thomas A Ficht; Donald S Davis; Philip H Elzer; Alfredo Wong-Gonzalez; Allison C Rice-Ficht
Journal:  J Wildl Dis       Date:  2009-01       Impact factor: 1.535

9.  Progress in Brucella vaccine development.

Authors:  Xinghong Yang; Jerod A Skyberg; Ling Cao; Beata Clapp; Theresa Thornburg; David W Pascual
Journal:  Front Biol (Beijing)       Date:  2013-02-01

10.  Efficacy of strain RB51 vaccine in protecting infection and vertical transmission against Brucella abortus in Sprague-Dawley rats.

Authors:  Md Ariful Islam; Mst Minara Khatun; Byeong-Kirl Baek; Sung-Il Lee
Journal:  J Vet Sci       Date:  2009-09       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.